Related references
Note: Only part of the references are listed.Glycoprotein E of the Japanese encephalitis virus forms virus-like particles and induces syncytia when expressed by a baculovirus
Ruikun Du et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Human Norovirus as a Foodborne Pathogen: Challenges and Developments
Matthew D. Moore et al.
ANNUAL REVIEW OF FOOD SCIENCE AND TECHNOLOGY, VOL 6 (2015)
Broad Blockade Antibody Responses in Human Volunteers after Immunization with a Multivalent Norovirus VLP Candidate Vaccine: Immunological Analyses from a Phase I Clinical Trial
Lisa C. Lindesmith et al.
PLOS MEDICINE (2015)
Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties
Yan Liu et al.
BMC MICROBIOLOGY (2014)
Epidemiology of human noroviruses and updates on vaccine development
Sasirekha Ramani et al.
CURRENT OPINION IN GASTROENTEROLOGY (2014)
Hantavirus Gn and Gc Glycoproteins Self-Assemble into Virus-Like Particles
Rodrigo Acuna et al.
JOURNAL OF VIROLOGY (2014)
Human Metapneumovirus Virus-Like Particles Induce Protective B and T Cell Responses in a Mouse Model
Reagan G. Cox et al.
JOURNAL OF VIROLOGY (2014)
Emergence of Zaire Ebola Virus Disease in Guinea
Sylvain Baize et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Characterization of Chikungunya Virus-Like Particles
Nitchakarn Noranate et al.
PLOS ONE (2014)
Efficient production of Japanese encephalitis virus-like particles by recombinant lepidopteran insect cells
Hideki Yamaji et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2013)
Virus-like particles: the future of microbial factories and cell-free systems as platforms for vaccine development
William A. Rodriguez-Limas et al.
CURRENT OPINION IN BIOTECHNOLOGY (2013)
Virus-like particles produced in plants as potential vaccines
Nunzia Scotti et al.
EXPERT REVIEW OF VACCINES (2013)
Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group
Raoul J. de Groot et al.
JOURNAL OF VIROLOGY (2013)
Construction and Characterization of Virus-Like Particles: A Review
Andris Zeltins
MOLECULAR BIOTECHNOLOGY (2013)
Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies
Shailendra Mani et al.
PLOS ONE (2013)
Virus-like particle-based human vaccines: quality assessment based on structural and functional properties
Qinjian Zhao et al.
TRENDS IN BIOTECHNOLOGY (2013)
Novel vaccine strategies against emerging viruses
Adolfo Garcia-Sastre et al.
CURRENT OPINION IN VIROLOGY (2013)
Effective Chikungunya Virus-like Particle Vaccine Produced in Insect Cells
Stefan W. Metz et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
HIV-1 Virus-Like Particles Produced by Stably Transfected Drosophila S2 Cells: a Desirable Vaccine Component
Lifei Yang et al.
JOURNAL OF VIROLOGY (2012)
Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase
Falko Schmeisser et al.
VACCINE (2012)
Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs
Dongni Kong et al.
VIROLOGY (2012)
Developments in virus-like particle-based vaccines for infectious diseases and cancer
Luigi Buonaguro et al.
EXPERT REVIEW OF VACCINES (2011)
Advances in Virus-Like Particle Vaccines for Filoviruses
Kelly L. Warfield et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Viruslike Particle Vaccine Induces Protection Against Respiratory Syncytial Virus Infection in Mice
Fu-Shi Quan et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Assembly and Immunological Properties of Newcastle Disease Virus-Like Particles Containing the Respiratory Syncytial Virus F and G Proteins
Lori W. McGinnes et al.
JOURNAL OF VIROLOGY (2011)
H5N1 Virus-Like Particle Vaccine Elicits Cross-Reactive Neutralizing Antibodies That Preferentially Bind to the Oligomeric Form of Influenza Virus Hemagglutinin in Humans
Surender Khurana et al.
JOURNAL OF VIROLOGY (2011)
Norovirus Vaccine against Experimental Human Norwalk Virus Illness
Robert L. Atmar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Vaccine Potential of Nipah Virus-Like Particles
Pramila Walpita et al.
PLOS ONE (2011)
Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico
Constantino Lopez-Macias et al.
VACCINE (2011)
Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice
Shuo Zhang et al.
VIROLOGY JOURNAL (2011)
Production of CCHF virus-like particle by a baculovirus-insect cell expression system
Zhao-rui Zhou et al.
VIROLOGICA SINICA (2011)
Norwalk virus-like particles as vaccines
Melissa Herbst-Kralovetz et al.
EXPERT REVIEW OF VACCINES (2010)
Virus-like particles in vaccine development
Antonio Roldao et al.
EXPERT REVIEW OF VACCINES (2010)
Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice
Baojing Lu et al.
IMMUNOLOGY (2010)
Paramyxovirus assembly and budding: Building particles that transmit infections
Megan S. Harrison et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Adjuvanted Intranasal Norwalk Virus-Like Particle Vaccine Elicits Antibodies and Antibody-Secreting Cells That Express Homing Receptors for Mucosal and Peripheral Lymphoid Tissues
Samer S. El-Kamary et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection
Wataru Akahata et al.
NATURE MEDICINE (2010)
The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza
Marc-Andre D'Aoust et al.
PLANT BIOTECHNOLOGY JOURNAL (2010)
Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza
Nathalie Landry et al.
PLOS ONE (2010)
Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice
Chuan Li et al.
VACCINE (2010)
A replication-incompetent Rift Valley fever vaccine: Chimeric virus-like particles protect mice and rats against lethal challenge
Robert B. Mandell et al.
VIROLOGY (2010)
Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
Luis M. Branco et al.
VIROLOGY JOURNAL (2010)
Chikungunya Fever: An Epidemiological Review of a Re-Emerging Infectious Disease
J. Erin Staples et al.
CLINICAL INFECTIOUS DISEASES (2009)
Noroviruses: A comprehensive review
Manish M. Patel et al.
JOURNAL OF CLINICAL VIROLOGY (2009)
Overview of the Flaviviridae With an Emphasis on the Japanese Encephalitis Group Viruses
Beth K. Schweitzer et al.
LABMEDICINE (2009)
Influenza vaccines based on virus-like particles
Sang-Moo Kang et al.
VIRUS RESEARCH (2009)
Cross-Clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-Like Particle
Rick A. Bright et al.
PLOS ONE (2008)
Virus-Like Particles of SARS-Like Coronavirus Formed by Membrane Proteins from Different Origins Demonstrate Stimulating Activity in Human Dendritic Cells
Bingke Bai et al.
PLOS ONE (2008)
Filovirus-like particles produced in insect cells: Immunogenicity and protection in rodents
Kelly L. Warfield et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus
Fu-Shi Quan et al.
JOURNAL OF VIROLOGY (2007)
Generation and analysis of infectious virus-like particles of Uukuniemi virus (Bunyavifidae):: a useful system for studying bunyaviral packaging and budding
Anna K. Overby et al.
JOURNAL OF VIROLOGY (2006)
Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections
DA Holmes et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation
L Buonaguro et al.
JOURNAL OF VIROLOGY (2005)
Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein
DE Purdy et al.
VIROLOGY (2005)
Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein
DL Swenson et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2004)
Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system
E Mortola et al.
FEBS LETTERS (2004)
Ebola virus-like particles protect from lethal Ebola virus infection
KL Warfield et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Lassa virus Z protein is a matrix protein sufficient for the release of virus-like particles
T Strecker et al.
JOURNAL OF VIROLOGY (2003)
Determinants of autoantibody induction by conjugated papillomavirus virus-like particles
B Chackerian et al.
JOURNAL OF IMMUNOLOGY (2002)
Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles
PR Harrington et al.
JOURNAL OF VIROLOGY (2002)
Share Paper
